Published in J Cancer Res Clin Oncol on July 30, 2009
Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br J Cancer (2011) 1.42
Association between novel PLCE1 variants identified in published esophageal cancer genome-wide association studies and risk of squamous cell carcinoma of the head and neck. BMC Cancer (2011) 0.91
Genetic polymorphisms in key DNA repair genes and risk of head and neck cancer in a Chinese population. Exp Ther Med (2012) 0.84
A naturally occurring feline model of head and neck squamous cell carcinoma. Patholog Res Int (2013) 0.84
Telomere length, genetic variants and risk of squamous cell carcinoma of the head and neck in Southeast Chinese. Sci Rep (2016) 0.81
The association between CBS 844ins68 polymorphism and head and neck squamous cell carcinoma risk - a case-control analysis. Arch Med Sci (2010) 0.79
Association of microRNA polymorphisms with the risk of head and neck squamous cell carcinoma in a Chinese population: a case-control study. Chin J Cancer (2016) 0.77
Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread. Clin Exp Metastasis (2013) 0.77
Systematic Review and Meta-Analysis of the Relationship between EPHX1 Polymorphisms and the Risk of Head and Neck Cancer. PLoS One (2015) 0.77
Genetic variation of fifteen folate metabolic pathway associated gene loci and the risk of incident head and neck carcinoma: the Women's Genome Health Study. Clin Chim Acta (2012) 0.76
DNA repair gene XRCC1 polymorphisms and head and neck cancer risk: an updated meta-analysis including 16344 subjects. PLoS One (2013) 0.75
Clinical Utility of Serum Homocysteine and Folate as Tumor Markers in Oral Squamous Cell Carcinoma - A Cross-Sectional Study. J Clin Diagn Res (2016) 0.75
Association between RAD51 polymorphisms and susceptibility of head and neck cancer: a meta-analysis. Int J Clin Exp Med (2015) 0.75
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med (2006) 25.67
Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer (1953) 11.45
Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst (2003) 6.28
Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res (1996) 4.89
Epstein-Barr virus gene expression in nasopharyngeal carcinoma. J Gen Virol (1988) 3.84
Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol (2006) 3.67
Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol (1999) 3.15
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial. Lancet (2003) 2.54
Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden. Cancer (1998) 2.51
Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol (2000) 2.45
Head and neck cancer: a global perspective on epidemiology and prognosis. Anticancer Res (1999) 2.24
The infratemporal fossa approach for nasopharyngeal tumors. Laryngoscope (1983) 1.93
Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res (2000) 1.91
Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res (1996) 1.80
Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol (2006) 1.76
Mobile phone use and risk of parotid gland tumor. Am J Epidemiol (2006) 1.67
The mechanism of action of radiosensitization of conventional chemotherapeutic agents. Semin Radiat Oncol (2003) 1.66
Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: A systematic review of the published literature with subgroup analysis. Head Neck (2001) 1.61
Occupation and larynx and hypopharynx cancer: a job-exposure matrix approach in an international case-control study in France, Italy, Spain and Switzerland. Cancer Causes Control (2003) 1.59
Plummer-Vinson syndrome. Orphanet J Rare Dis (2006) 1.52
The infratemporal fossa approach for the lateral skull base. Otolaryngol Clin North Am (1984) 1.52
Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer (1994) 1.51
Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Int J Cancer (2000) 1.47
Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck (2002) 1.45
Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer (1996) 1.37
Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe. Am J Epidemiol (2006) 1.35
Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol (2003) 1.30
Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience. Int J Radiat Oncol Biol Phys (2006) 1.29
Concurrent radiotherapy and chemotherapy with cisplatin in inoperable squamous cell carcinoma of the head and neck. An RTOG Study. Cancer (1987) 1.20
Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14). Int J Radiat Oncol Biol Phys (2008) 1.18
Adulthood consumption of preserved and nonpreserved vegetables and the risk of nasopharyngeal carcinoma: a systematic review. Int J Cancer (2006) 1.16
The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck. J Oral Pathol Med (2000) 1.16
p53 mutations in head and neck cancer: new data and evaluation of mutational spectra. Cancer Epidemiol Biomarkers Prev (1997) 1.09
Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope (1992) 1.07
Smoking, alcohol drinking and cancer risk for various sites of the larynx and hypopharynx. A case-control study in France. Eur J Cancer Prev (2004) 1.07
Failure at distant sites following multimodality treatment for advanced head and neck cancer. Head Neck Surg (1984) 1.06
Applying radiobiological principles to combined modality treatment of head and neck cancer--the time factor. Int J Radiat Oncol Biol Phys (1997) 1.06
Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiat Oncol Biol Phys (1997) 1.05
Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesis. Clin Cancer Res (2004) 1.05
Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer--a review of their cooperation. Acta Oncol (2003) 1.04
Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas. J Clin Pathol (2002) 1.04
A mechanism of cisplatin action: antineoplastic effect through inhibition of neovascularization. Kobe J Med Sci (1997) 1.03
Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Swed Dent J Suppl (2005) 1.03
The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation. Health Technol Assess (2006) 1.02
Salvage surgery with free flap reconstruction: factors affecting outcome after treatment of recurrent head and neck squamous carcinoma. Laryngoscope (2007) 0.99
Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma: is salvage possible? Arch Otolaryngol Head Neck Surg (2004) 0.98
Chemoradiotherapy: emerging treatment improvement strategies. Head Neck (2003) 0.97
Photodynamic therapy of malignant and premalignant lesions in patients with 'field cancerization' of the oral cavity. J Laryngol Otol (1993) 0.97
Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa. J Cancer Res Clin Oncol (2006) 0.95
Neutron radiotherapy for adenoid cystic carcinoma of minor salivary glands. Int J Radiat Oncol Biol Phys (1996) 0.93
Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer. Head Neck (2005) 0.92
Health risks associated with inhaled nasal toxicants. Crit Rev Toxicol (2001) 0.90
The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases. Mod Pathol (2003) 0.88
Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case series. Head Neck (2005) 0.88
24-hour infusion of cis-platinum in head and neck cancers. Cancer (1978) 0.87
Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma. Laryngoscope (2006) 0.86
Radiation therapy and concurrent cisplatin in management of locoregionally advanced nasopharyngeal carcinomas. Acta Oncol (1999) 0.86
Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience. Head Neck (1994) 0.86
Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas. Int J Radiat Oncol Biol Phys (2006) 0.86
Laryngeal and hypopharyngeal cancer and occupational exposure to asbestos and man-made vitreous fibers: results of a case-control study. Am J Ind Med (2000) 0.86
A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas. Radiother Oncol (2006) 0.85
Radiotherapy and concurrent chemotherapy for the treatment of locally advanced head and neck squamous cell carcinoma. Semin Radiat Oncol (1998) 0.84
Lifestyles, environmental and phenotypic factors associated with lip cancer: a case-control study in southern Spain. Br J Cancer (2003) 0.83
Simultaneous cis-platinum and radiotherapy in inoperable or locally advanced squamous cell carcinoma of the head and neck. Oncology (1991) 0.82
Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers. Carcinogenesis (2000) 0.82
[Effectiveness of recombinant adenovirus p53 injection on laryngeal cancer: phase I clinical trial and follow up]. Zhonghua Yi Xue Za Zhi (2003) 0.82
Photodynamic treatment of oral lesions. J Environ Pathol Toxicol Oncol (2007) 0.81
Preventable risk factors for nasal cancer. Ann Epidemiol (2000) 0.80
Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience. Arch Otolaryngol Head Neck Surg (2007) 0.79
Inhibitory effect of neoadjuvant chemotherapy on metastasis of oral squamous cell carcinoma in a mouse model. Oral Oncol (2009) 0.77
Combined radiotherapy and chemotherapy for nasopharyngeal carcinoma. Semin Radiat Oncol (1998) 0.77
Organ and function preservation: the role of surgery as the optimal primary modality or as salvage after chemoradiation failure. Semin Radiat Oncol (2009) 0.76
Concurrent chemo-irradiation using accelerated concomitant boost radiation therapy in loco-regionally advanced head and neck squamous cell carcinomas. J Cancer Res Ther (2007) 0.76
Cis-diamminedichloroplatinum (II) administered by 24-hour infusion in the treatment of patients with advanced upper aerodigestive cancer. Cancer (1983) 0.75
[Evaluating the effectiveness of chemotherapy in patients with head-neck tumors using positron emission tomography (PET scan)]. HNO (1992) 0.75
The human papilloma virus, the vaccines, and oral and oropharyngeal squamous cell carcinoma: what every dentist should know. Gen Dent (2007) 0.75
Split hyperfractionated accelerated radiation therapy and concomitant cisplatin for locally advanced head and neck carcinomas: a preliminary report. Int J Radiat Oncol Biol Phys (1995) 0.75
Photodynamic therapy of oral cancer. A review of basic mechanisms and clinical applications. Eur J Oral Sci (1996) 0.75
Chemotherapy for advanced and recurrent squamous cell carcinoma of the head and neck with high and low dose cis-diamminedichloroplatinum. Am J Surg (1978) 0.75
Cisplatin sensitization to radiotherapy of squamous cell carcinomas of the head and neck. Am J Surg (1983) 0.75
[Locoregional recurrence of ORL cancer: the place of surgery]. Bull Cancer (2004) 0.75
Concomitant cisplatin and hyperfractionated external beam irradiation for advanced malignancy of the head and neck. Am J Surg (1991) 0.75
Patterns of treatment failure and prognostic factors associated with the treatment of esophageal carcinoma with chemotherapy and radiotherapy either as sole treatment or followed by surgery . J Clin Oncol (1992) 1.70
Factors influencing outcome following radio-chemotherapy for oesophageal cancer. The Trans Tasman Radiation Oncology Group (TROG) Radiother Oncol (1996) 1.50
Designing a prehospital system for a developing country: estimated cost and benefits. Am J Emerg Med (1997) 0.98
'GAP' in radiotherapy services in Australia and New Zealand in 2009. J Med Imaging Radiat Oncol (2010) 0.91
Single-dose comparative kinetics and bioavailability study of quinine hydrochloride, quinidine sulfate and quinidine bisulfate sustained-release in healthy male volunteers. Acta Leiden (1988) 0.90
Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study. Int J Radiat Oncol Biol Phys (1995) 0.89
Treatment of adenocarcinoma of the cardia with synchronous chemotherapy and radiotherapy. Br J Surg (1990) 0.88
Intravenous immunoglobulin induces interferon-gamma and interleukin-6 in vivo. J Clin Immunol (1993) 0.85
Measurement of reoxygenation during fractionated radiotherapy in head and neck squamous cell carcinoma xenografts. Australas Phys Eng Sci Med (2010) 0.81
Efficient Monte Carlo modelling of individual tumour cell propagation for hypoxic head and neck cancer. Phys Med Biol (2008) 0.81
Out-of-field neutron and leakage photon exposures and the associated risk of second cancers in high-energy photon radiotherapy: current status. Radiat Res (2011) 0.80
A comparison of quantitative coronary angiography systems using a unique set of in vivo coronary stenosis images. Can J Cardiol (2001) 0.79
Effects of fractionated abdominal irradiation on small intestinal motility--studies in a novel in vitro animal model. Acta Oncol (1997) 0.77
The HYP-RT hypoxic tumour radiotherapy algorithm and accelerated repopulation dose per fraction study. Comput Math Methods Med (2012) 0.77
Small intestinal dysmotility following abdominal irradiation in the rat small intestine. Neurogastroenterol Motil (1998) 0.76
Anorectal dysfunction following irradiation for uterine carcinoma: comment on Kim et al. IJROBP 41:835-841; 1998. Int J Radiat Oncol Biol Phys (1999) 0.75
Radiation oncology registrar training in Adelaide. Australas Radiol (1997) 0.75
Regulation of Fc-induced IL-6 from human peripheral blood mononuclear cells. Cytokine (1993) 0.75
Percutaneous needle cricothyroidotomy with repetitive airway obstruction. Am J Emerg Med (1995) 0.75
The influence of recombinant mediators on in vitro IgG subclass secretion by peripheral blood mononuclear cells from patients with hypogammaglobulinemia and from normal donors. Eur Cytokine Netw (1994) 0.75
Feasibility study on the MammoSite in early-stage breast cancer: initial experience. Australas Radiol (2007) 0.75